Knowledge of genetic testing for hereditary kidney cancer in Canada is lacking: The results of the Canadian national hereditary kidney cancer needs assessment survey

被引:6
作者
Violette, Philippe D. [1 ]
Kamel-Reid, Suzanne [2 ]
Graham, Gail E. [3 ,4 ]
Reaume, M. Neil [4 ,5 ]
Jewett, Michael A. [6 ]
Care, Melanie [7 ]
Basiuk, Joan [8 ]
Pautler, Stephen E. [1 ,9 ]
机构
[1] Univ Western Ontario, Schulich Sch Med & Dent, Dept Surg, Div Urol, London, ON, Canada
[2] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada
[3] Childrens Hosp Eastern Ontario, Eastern Ontario Reg Genet Program, Ottawa, ON K1H 8L1, Canada
[4] Univ Ottawa, Ottawa, ON, Canada
[5] Ottawa Hosp Canc Ctr, Div Med Oncol, Ottawa, ON, Canada
[6] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Dept Surg Oncol, Toronto, ON, Canada
[7] Univ Hlth Network, Dept Mol Genet, Toronto, ON, Canada
[8] Kidney Canc Res Network Canada, Toronto, ON, Canada
[9] Univ Western Ontario, Schulich Sch Med & Dent, Dept Oncol, Div Surg Oncol, London, ON, Canada
来源
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2014年 / 8卷 / 11-12期
关键词
HIPPEL-LINDAU DISEASE; PERSONALIZED MEDICINE; BARRIERS; HETEROGENEITY; CARCINOMA;
D O I
10.5489/cuaj.2415
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Treatment of hereditary renal cell carcinoma (HRCC) requires a multidisciplinary approach that may involve medical oncologists, geneticists, genetic counsellors, and urologists. The objective of our survey was to obtain current and representative information about the use and perceived importance of genetic testing for HRCC in Canada. Methods: A self-administered web-based survey was provided to Canadian medical oncologists, geneticists, genetic counsellors, and urologists in collaboration with their respective associations. The survey was created through an iterative process in consultation with the Kidney Cancer Research Network of Canada and contained both quantitative and qualitative components. The survey was designed to be exploratory and results were compared across regions. Results: The overall response was low (6.6%). Of the respondents, 42%, 33%, 19%, 5% were genetic counsellors, urologists, medical oncologists and medical geneticists, respectively. Of the respondents, 62.7% described their practice as academic, and 37.3% described it as non-academic. Non-academic respondents tended to refer for genetic counselling less frequently than academic (48.6% vs. 67.2%). Most respondents believed that genetic testing for HRCC was available (82.8%), although 47.7% did not know which tests were available. This observation was consistent across provinces. Testing for Von Hippel-Lindau syndrome was given the highest priority among respondents. Limited provider knowledge, clinical guidelines, institutional funding, access, and poor coordination between disciplines were cited as barriers to testing. Interpretation: There is a need to increase provider knowledge of genetic testing for HRCC. These findings support the development of practice guidelines and national strategies to improve coordination of specialists and access to genetics services. Limitations of the present study include low survey response which did not allow for inferential analysis by geographic region or respondent specialty.
引用
收藏
页码:E832 / E840
页数:9
相关论文
共 33 条
  • [21] Qualitative description - the poor cousin of health research?
    Neergaard, Mette Asbjoern
    Olesen, Frede
    Andersen, Rikke Sand
    Sondergaard, Jens
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2009, 9
  • [22] *ONT GEN SECR, 2009, GEN TEST RES CONTR F
  • [23] Surveillance in von Hippel-Lindau disease (vHL)
    Poulsen, M. L. M.
    Budtz-Jorgensen, E.
    Bisgaard, M. L.
    [J]. CLINICAL GENETICS, 2010, 77 (01) : 49 - 59
  • [24] Canadian guideline on genetic screening for hereditary renal cell cancers
    Reaume, M. Neil
    Graham, Gail E.
    Tomiak, Eva
    Kamel-Reid, Suzanne
    Jewett, Michael A. S.
    Bjarnason, Georg A.
    Blais, Normand
    Care, Melanie
    Drachenberg, Darryl
    Gedye, Craig
    Grant, Ronald
    Heng, Daniel Y. C.
    Kapoor, Anil
    Kollmannsberger, Christian
    Lattouf, Jean-Baptiste
    Maher, Eamonn R.
    Pause, Arnim
    Ruether, Dean
    Soulieres, Denis
    Tanguay, Simon
    Turcotte, Sandra
    Violette, Philippe D.
    Wood, Lori
    Basiuk, Joan
    Pautler, Stephen E.
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (9-10): : 319 - 323
  • [25] Succinate Dehydrogenase Kidney Cancer: An Aggressive Example of the Warburg Effect in Cancer
    Ricketts, Christopher J.
    Shuch, Brian
    Vocke, Cathy D.
    Metwalli, Adam R.
    Bratslavsky, Gennady
    Middelton, Lindsay
    Yang, Youfeng
    Wei, Ming-Hui
    Pautler, Stephen E.
    Peterson, James
    Stolle, Catherine A.
    Zbar, Berton
    Merino, Maria J.
    Schmidt, Laura S.
    Pinto, Peter A.
    Srinivasan, Ramaprasad
    Pacak, Karel
    Linehan, W. Marston
    [J]. JOURNAL OF UROLOGY, 2012, 188 (06) : 2063 - 2071
  • [26] The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma
    Shoji, Sunao
    Nakano, Mayura
    Sato, Haruhiro
    Tang, Xian Yang
    Osamura, Yoshiyuki Robert
    Terachi, Toshiro
    Uchida, Toyoaki
    Takeya, Koichi
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2014, 31 (01) : 111 - 134
  • [27] Defining Early-Onset Kidney Cancer: Implications for Germline and Somatic Mutation Testing and Clinical Management
    Shuch, Brian
    Vourganti, Srinivas
    Ricketts, Christopher J.
    Middleton, Lindsay
    Peterson, James
    Merino, Maria J.
    Metwalli, Adam R.
    Srinivasan, Ramaprasad
    Linehan, W. Marston
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (05) : 431 - 437
  • [28] Cancer statistics, 2013
    Siegel, Rebecca
    Naishadham, Deepa
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2013, 63 (01) : 11 - 30
  • [29] The wide gap between genetic research and clinical needs
    Silversides, Ann
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (03) : 315 - 316
  • [30] Trepanier Angela, 2004, J Genet Couns, V13, P83, DOI 10.1023/B:JOGC.0000018821.48330.77